Following AstraZeneca’s temporary halt to vaccine trials, the WHO said it is not uncommon. So said the WHO statement from AstraZeneca on the temporary suspension of the vaccination trial

New Delhi: The World Health Organization (WHO) announced on Wednesday that the ‘temporary suspension’ of the COVID-19 vaccine trial being conducted simultaneously by AstraZeneca and Oxford University is not uncommon. The announcement comes after reports that a person has developed a disease through a vaccination test. However, this person has not been told about what kind of malaise.

The WHO has also stated that ‘safety is paramount in clinical trials’ of vaccines, and that suspension is common in any participant to determine the cause of unexplained disease.

Also read: Foreign Minister of Russia, India, China meets in Moscow: Chinese Ministry of Foreign Affairs

Let us know that AstraZeneca on Wednesday canceled worldwide trials of its potential coronavirus vaccine. This has led to a decline in the shares of this British medicine maker. The possibilities that the vaccine will soon be on the market have also diminished. The WHO has said: “We are pleased to see that vaccine developers are very aware of the trials. They follow standard guidelines and rules for developing vaccines with the utmost sincerity.

The organization also pushed for “strict adherence to all protocols to protect volunteers and make the vaccine more effective.”

This epidemic is not the last

World Health Organization head Tedros Edholm Ghebriasis said on Monday that the world must prepare for another epidemic. Not only this, the preparation should be better this time. He also urged all countries to invest in public health.

During a newsletter in Geneva, Tedros said: “This will not be the last pandemic. History teaches us that outbreaks and pandemics are part of life. So when the next pandemic comes, the world should be ready. Be better prepared than this time.

As for vaccination, the World Health Organization said Friday it does not expect widespread vaccination against Kovid-19 by the middle of next year. He considers the importance of strict monitoring of the effectiveness and safety of any potential vaccine. WHO spokesman Margaret Harris said, “We don’t really expect a widespread vaccination midway through next year.”